These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7962321)

  • 1. Deletion of 3 basepairs resulting in the loss of lysine-121 in the insulin receptor alpha-subunit in a patient with leprechaunism: binding, phosphorylation, and biological activity.
    Jospe N; Zhu J; Liu R; Livingston JN; Furlanetto RW
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1294-302. PubMed ID: 7962321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subject.
    George S; Johansen A; Soos MA; Mortensen H; Gammeltoft S; Saudek V; Siddle K; Hansen L; O'Rahilly S
    Endocrinology; 2003 Feb; 144(2):631-7. PubMed ID: 12538626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of Asn281 in the alpha-subunit of the human insulin receptor causes constitutive activation of the receptor and insulin desensitization.
    Desbois-Mouthon C; Sert-Langeron C; Magre J; Oreal E; Blivet MJ; Flori E; Besmond C; Capeau J; Caron M
    J Clin Endocrinol Metab; 1996 Feb; 81(2):719-27. PubMed ID: 8636294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional properties of a naturally occurring Trp1200----Ser1200 mutation of the insulin receptor.
    Moller DE; Yokota A; Ginsberg-Fellner F; Flier JS
    Mol Endocrinol; 1990 Aug; 4(8):1183-91. PubMed ID: 1963473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism.
    Takahashi Y; Kadowaki H; Momomura K; Fukushima Y; Orban T; Okai T; Taketani Y; Akanuma Y; Yazaki Y; Kadowaki T
    Diabetologia; 1997 Apr; 40(4):412-20. PubMed ID: 9112018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe resistance to insulin and insulin-like growth factor-I in cells from a patient with leprechaunism as a result of two mutations in the tyrosine kinase domain of the insulin receptor.
    Desbois-Mouthon C; Danan C; Amselem S; Blivet-Van Eggelpoel MJ; Sert-Langeron C; Goossens M; Besmond C; Capeau J; Caron M
    Metabolism; 1996 Dec; 45(12):1493-500. PubMed ID: 8969282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four mutant alleles of the insulin receptor gene associated with genetic syndromes of extreme insulin resistance.
    Kadowaki H; Takahashi Y; Ando A; Momomura K; Kaburagi Y; Quin JD; MacCuish AC; Koda N; Fukushima Y; Taylor SI; Akanuma Y; Yazaki Y; Kadowaki T
    Biochem Biophys Res Commun; 1997 Aug; 237(3):516-20. PubMed ID: 9299395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two mutations in the insulin receptor gene of a patient with leprechaunism: application to prenatal diagnosis.
    Longo N; Langley SD; Griffin LD; Elsas LJ
    J Clin Endocrinol Metab; 1995 May; 80(5):1496-501. PubMed ID: 7538143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of glucose transport by a natural mutation in the human insulin receptor.
    Longo N; Langley SD; Griffin LD; Elsas LJ
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):60-4. PubMed ID: 8419945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the N-linked glycosylation sites of the human insulin receptor.
    Elleman TC; Frenkel MJ; Hoyne PA; McKern NM; Cosgrove L; Hewish DR; Jachno KM; Bentley JD; Sankovich SE; Ward CW
    Biochem J; 2000 May; 347 Pt 3(Pt 3):771-9. PubMed ID: 10769182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An insulin receptor mutant (Asp707 --> Ala), involved in leprechaunism, is processed and transported to the cell surface but unable to bind insulin.
    Hart LM; Lindhout D; Van der Zon GC; Kayserilli H; Apak MY; Kleijer WJ; Van der Vorm ER; Maassen JA
    J Biol Chem; 1996 Aug; 271(31):18719-24. PubMed ID: 8702527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A leucine to proline mutation at position 233 in the insulin receptor inhibits cleavage of the proreceptor and transport to the cell surface.
    Maassen JA; Van der Vorm ER; Van der Zon GC; Klinkhamer MP; Krans HM; Möller W
    Biochemistry; 1991 Nov; 30(44):10778-83. PubMed ID: 1931997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of the insulin receptor beta-subunit acidic domain results in enhanced metabolic signaling.
    Rolband GC; Williams JF; Webster NJ; Olefsky JM
    Endocrinology; 1993 Sep; 133(3):1437-43. PubMed ID: 8396020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arginine 86 of the insulin receptor in insulin binding and activation of glucose transport.
    Longo N; Langley SD; Still MJ
    Biochim Biophys Acta; 1998 Mar; 1402(1):86-94. PubMed ID: 9551089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An arginine to cysteine(252) mutation in insulin receptors from a patient with severe insulin resistance inhibits receptor internalisation but preserves signalling events.
    Hamer I; Foti M; Emkey R; Cordier-Bussat M; Philippe J; De Meyts P; Maeder C; Kahn CR; Carpentier JL
    Diabetologia; 2002 May; 45(5):657-67. PubMed ID: 12107746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of C-terminal 113 amino acids impairs processing and internalization of human insulin receptor: comparison of receptors expressed in CHO and NIH-3T3 cells.
    Levy-Toledano R; Accili D; Taylor SI
    Biochim Biophys Acta; 1993 Dec; 1220(1):1-14. PubMed ID: 8268238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3-basepair in-frame deletion (delta Leu999) in exon 17 of the insulin receptor gene in a family with insulin resistance.
    Awata T; Matsumoto C; Momomura K; Takahashi Y; Odawara M; Kasuga M; Kadowaki T; Iwamoto Y
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1840-4. PubMed ID: 7989492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of residues 485-599 from the human insulin receptor abolishes antireceptor antibody binding and influences tyrosine kinase activation.
    Sung CK; Wong KY; Yip CC; Hawley DM; Goldfine ID
    Mol Endocrinol; 1994 Mar; 8(3):315-24. PubMed ID: 8015549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptor autophosphorylation and exogenous substrate phosphorylation: role of receptor C-terminus and effects of mild reduction.
    Clark S; Konstantopoulos N
    Biochem Biophys Res Commun; 1994 Apr; 200(1):330-7. PubMed ID: 8166701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution of glutamine for arginine 1131. A newly identified mutation in the catalytic loop of the tyrosine kinase domain of the human insulin receptor.
    Kishimoto M; Hashiramoto M; Yonezawa K; Shii K; Kazumi T; Kasuga M
    J Biol Chem; 1994 Apr; 269(15):11349-55. PubMed ID: 7512563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.